Mobenakin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMobenakin
Drug Alias NameInterleukin-1 beta muteinOCT-43
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor agonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsUrogenital NeoplasmsGliomaLymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsUrogenital NeoplasmsGliomaLymphoma

Other Information

ATC CodeN/A
Related LinksN/A